Saxagliptin failed to meet its primary efficacy endpoint in a clinical trial designed to assess whether the drug reduced the risk of cardiovascular events when used alone or added to other diabetes medications.
Fifteen minutes sooner, four in 1,000 more lives saved. That appears to be the benefit ratio for timely reperfusion of patients who present with acute ischemic stroke, according to results published June 19 in the JAMA.
ATLANTA—Improve quality, reduce cost. That’s often the goal, but less often the outcome. The leader of an integrated electrophysiology (EP) program shared a formula for achieving quality and savings June 13 at the Cardiovascular Service Line Symposium.
A Medicare advisory panel recommended changes to Congress that included initiatives to reduce payment differences between hospital outpatient and physician office payment rates. One option targeted cardiac imaging services for a projected annual savings of $500 million.
ATLANTA—Opportunities exist within many cardiovascular programs to trim out costs and add value. But where? Suzette Jaskie, president and CEO of MedAxiom Consulting, offered five “slam dunk” approaches June 13 at the Cardiovascular Service Line Symposium in Atlanta.
